Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
Idiopathic pulmonary fibrosis (IPF) is one of the most common and devastating interstitial lung diseases with poor prognosis. Currently, few effective drugs are available for IPF. Hence, we sought to explore the role of mefunidone (MFD), a newly synthesized drug developed by our team, in lung fibros...
Main Authors: | Yuanyuan Han, Mao Jiang, Rongling He, Xin Lv, Xiaohua Liao, Yijun He, Fan Zhang, Lingzhi Long, Guoliang Jiang, Zhangzhe Peng, Lijian Tao, Gaoyun Hu, Jie Meng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.713572/full |
Similar Items
-
Mefunidone attenuates tubulointerstitial fibrosis in a rat model of unilateral ureteral obstruction.
by: Chunyan Liu, et al.
Published: (2015-01-01) -
Urinary coenzyme Q10 as a diagnostic biomarker and predictor of remission in a patient with ADCK4-associated Glomerulopathy: a case report
by: Yan Zhang, et al.
Published: (2021-01-01) -
A Retrospective Cohort Study on the Clinical Course of Patients With Moderate-Type COVID-19
by: Xiaohua Liao, et al.
Published: (2021-04-01) -
Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway
by: Qin Dai, et al.
Published: (2020-12-01) -
The Protective Effect of Fluorofenidone against Cyclosporine A-Induced Nephrotoxicity
by: Yang Chen, et al.
Published: (2019-08-01)